Recent Finacing
Recent Raise
Sulfiscon develops small-molecule allosteric modulators for pathological calcification, operating from Biopôle’s StartLab in Epalinges with a small team pursuing preclinical in vivo efficacy and safety studies.
Recent Investors
Total Raised
Funding round
Investor